Precision Prevention of Prostate Cancer Lab (PRE2 CAP Lab)
Prostate cancer remains the most commonly diagnosed non-cutaneous cancer in men, with an estimated 1.4 million new diagnoses each year worldwide. The PRE2 CAP laboratory aims to discover environmental risk factors for prostate cancer, and address barriers to appropriate prostate cancer screening and treatment through application of geospatial analytic methods. Please visit our laboratory webpage to learn more about our work.
Dr. Iyer’s research is funded by Prostate Cancer Research, a UK-based charity and the National Institutes of Environmental Health Sciences. He co-leads a registry-based cohort study of Black and White men with prostate cancer to study how neighborhood social and physical environments influence access to screening and racial disparities. In addition, he has launched a study to investigate drinking water exposure to per- and polyfluoroalkyl substances (PFAS) in relation to prostate cancer outcomes.
Dr. Iyer has co-authored over 70 peer-reviewed publications across multiple fields of public health, including cancer epidemiology, environmental health, and global health. He earned his ScD at the Harvard T. H. Chan School of Public Health and completed postdoctoral training at the Dana-Farber Cancer Institute.
View Dr. Iyer's Researcher Profile
Funding for our laboratory is generously provided by:
- Prostate Cancer Research, UK
- NIEHS K01ES035734
- Rutgers Cancer Institute Cancer Prevention and Control Stimulus Award
- Rutgers Global Health Institute